VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
67 hedge funds and large institutions have $65.1M invested in Vincerx Pharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
67
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.08M | |
| 2 | +$1.16M | |
| 3 | +$1.13M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$955K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$653K |
Top Sellers
| 1 | -$7.55M | |
| 2 | -$4.02M | |
| 3 | -$167K | |
| 4 |
NFGH
Nan Fung Group Holdings
Kai Tak,
Hong Kong
|
-$113K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$110K |